Annet Z. Vos-Brouwers
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
MLL-AF9 expression levels do not instruct lineage fate.
Journal: Haematologica
Published: December 10, 2025
Elastic properties of leukemic cells linked to maturation stage and integrin activation.
Journal: iScience
Published: October 14, 2024
The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia.
Journal: Nature communications
Published: June 13, 2021
The USP7-TRIM27 axis mediates non-canonical PRC1.1 function and is a druggable target in leukemia.
Journal: iScience
Published: November 25, 2020
HUWE1 cooperates with RAS activation to control leukemia cell proliferation and human hematopoietic stem cells differentiation fate.
Journal: Cancer gene therapy
Published: March 24, 2020
HIF1/2-exerted control over glycolytic gene expression is not functionally relevant for glycolysis in human leukemic stem/progenitor cells.
Journal: Cancer & metabolism
Published: July 17, 2019
Transcriptional regulators CITED2 and PU.1 cooperate in maintaining hematopoietic stem cells.
Journal: Experimental hematology
Published: January 24, 2019
Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones.
Journal: Cancer cell
Published: March 30, 2018
BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9+ leukemic cells.
Journal: PloS one
Published: July 07, 2017
Last Updated: 09/26/2026